BAGNARELLI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 5.606
EU - Europa 2.517
AS - Asia 876
AF - Africa 124
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
SA - Sud America 5
Totale 9.139
Nazione #
US - Stati Uniti d'America 5.596
UA - Ucraina 624
IT - Italia 374
IE - Irlanda 351
SG - Singapore 330
SE - Svezia 295
DE - Germania 284
DK - Danimarca 224
CN - Cina 203
TR - Turchia 189
FI - Finlandia 139
KR - Corea 119
CI - Costa d'Avorio 113
GB - Regno Unito 104
FR - Francia 82
BE - Belgio 20
IN - India 19
MA - Marocco 9
CA - Canada 8
PK - Pakistan 7
EU - Europa 5
JP - Giappone 4
AU - Australia 3
CZ - Repubblica Ceca 3
NL - Olanda 3
AR - Argentina 2
CM - Camerun 2
ES - Italia 2
HR - Croazia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PY - Paraguay 2
A1 - Anonimo 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
HK - Hong Kong 1
HU - Ungheria 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
NO - Norvegia 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 9.139
Città #
Des Moines 748
Chandler 700
Jacksonville 641
Fairfield 479
Dublin 349
Boardman 334
Ashburn 317
Wilmington 224
Woodbridge 203
Seattle 169
Houston 166
New York 160
San Mateo 142
Singapore 142
Lawrence 139
Princeton 139
Ann Arbor 131
Cambridge 117
Abidjan 113
Civitanova Marche 96
San Diego 67
Beijing 44
Redmond 33
Turin 32
Centro 31
Washington 30
Marche 27
London 23
Helsinki 22
Brussels 20
Norwalk 20
Shanghai 19
Los Angeles 18
Bari 15
Wuhan 10
Iesi 9
Rome 9
Ancona 8
Guangzhou 8
Falls Church 7
Hanover 6
Pune 6
Chiswick 5
Cingoli 5
Jiaxing 5
Yiwu 5
Acton 4
Dallas 4
Kilburn 4
Milan 4
Mumbai 4
Ottawa 4
Santa Vittoria In Matenano 4
Shenzhen 4
Appignano 3
Delhi 3
Hounslow 3
Izmir 3
Porto 3
Prescot 3
Tolentino 3
Aci Castello 2
Andover 2
Arco 2
Asunción 2
Birmingham 2
Bologna 2
Caserta 2
Cava De' Tirreni 2
Fayetteville 2
Köseköy 2
Lodi 2
Macerata 2
Miami Beach 2
Munro 2
New Bedfont 2
Osimo 2
Pesaro 2
Phoenix 2
Porto San Giorgio 2
Quanzhou 2
Redwood City 2
San Benedetto del Tronto 2
Santa Clara 2
Seoul 2
Southend 2
Southwark 2
Taiyuan 2
Torre Annunziata 2
Wuxi 2
Zagreb 2
Atlanta 1
Auckland 1
Bathgate 1
Belgrade 1
Belvedere Spinello 1
Budapest 1
Cagliari 1
Calgary 1
Cantu 1
Totale 6.115
Nome #
Antimicrobial Resistance: A Challenge for the Future 162
Evaluation of the Ion AmpliSeq SARS-CoV-2 Research Panel by Massive Parallel Sequencing 114
Competitive polymerase chain reaction and analysis of viral activity at the molecular level. 102
Hepatitis E in a region of Italy: An emerging autochthonous infection? 102
Long-term maintenance of virologic suppression in native and migrant HIV-1 naïve patients: an Italian cohort study 102
[Acute respiratory infections caused by viruses, mycoplasmas, rickettsias and chlamydias with bronchial and pulmonary localization. 2 year's experience in the province of Ancona] 101
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 101
[Adaptation to defined chemical conditions of the in vitro growth of PLC/PRF/5 cells] 98
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. 98
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 98
A combination of nucleoside analogues and a protease inhibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection. 97
Survey of diagnostic and typing capacity for enterovirus infection in Italy and identification of two echovirus 30 outbreaks 95
Anti-HIV-1 Response Elicited in Rabbits by Anti-Idiotype Monoclonal Antibodies Mimicking the CD4-Binding Site. 93
A serum-free growth of a human hepatoma cell line as a tool for hepatocarcinogenesis and virus gene expression. 93
Molecular Characterization of Italian Isolates of Fluoroquinolone-Resistant Streptococcus agalactiae and Relationships with Chloramphenicol Resistance 92
Analysis of the functional relationship between V3 loop and gp120 context with regard to human immunodeficiency virus coreceptor usage using naturally selected sequences and different viral backbones. 90
Changes in CD8 cell subpopulations induced by antiretroviral therapy in human immunodeficiency virus infected patients. 88
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen. 87
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. 86
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. 86
Complement-fixation test for rotavirus detection: comparison and analysis of different methods to reduce anti-complementary activity of some specimens. 85
Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection. 85
A single-step DNA extraction procedure for the detection of serum hepatitis B virus sequences by the polymerase chain reaction. 85
Abstract [Cross-over electrophoresis on cellulose acetate. A new method for rapid diagnosis of rotavirus infection] 85
[Respiratory tract infections caused by viruses, Mycoplasma, Rickettsia and Chlamydia with bronchial and pulmonary localization] 83
Quantification of the HIV-1 total reservoir in the peripheral blood of naïve and treated patients by a standardised method derived from a commercial HIV-1 RNA quantification assay. 83
Diagnosis of human rotavirus infections: comparison of an electrophoretic method, a modified complement fixation test and electron microscopy for rotavirus detection. 82
Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay. 82
Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure. 81
Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. 81
Quantitation of HIV-1 genome copy number in semen and saliva. 81
Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals. 81
HIV-1 A1 subtype epidemic in Italy originated from Africa and Eastern Europe and shows a high frequency of transmission chains involving intravenous drug users 81
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 81
Comparative effects of alpha, beta and gamma human interferons on a HBsAg-producing human hepatoma cell line. 80
Modulation of production of hepatitis B surface antigen by a human hepatoma cell line. 80
Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates 80
A human hepatoma cell line modulates its insulin receptors under different culture conditions. 79
Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren's syndrome 79
Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors 79
Genotypic and phenotypic correlates of the HIV Type 1 env gene evolution in infected children with discordant response to antiretroviral therapy. 77
Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis. 77
Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy. 76
Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. 76
Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment. 76
Early increase of CD4+ CD45RA+ and CD4+ CD95- cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients. 75
Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. 75
Human growth hormone induced modulation of hepatitis B virus (HBV) gene expression. 75
Characterization of a Streptococcus suis tet(O/W/32/O)-carrying element transferable to major streptococcal pathogens. 75
Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types 75
Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. 74
Quantitative molecular methods in virology. 74
Characterization of growth parameters of a human hepatoma cell line cultured under serum-free conditions. 74
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 74
[Hepatocarcinoma cell lines in vitro: binding of insulin] 73
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study 73
Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. 72
Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus. 72
Processivity and drug-dependence of HIV-1 protease: determinants of viral fitness in variants resistant to protease inhibitors. 71
Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjects. 71
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes. 71
Quantitative PCR and RT-PCR in virology. 70
Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange 70
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 70
Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressors. 69
Local Epidemics Gone Viral: Evolution and Diffusion of the Italian HIV-1 Recombinant Form CRF60_BC 69
Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy. 68
Inhibition of HIV-1 Tat activity correlates with down-regulation of bcl-2 and results in reduction of angiogenesis and oncogenicity. Virology. 2002 Jul 20;299(1):1-7. 68
Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets. 68
Detection of hepatitis B virus DNA in serum using synthetic non-radioactive oligonucleotides. 68
Differential response of the human hepatoma-derived cell line HA22T/VGH to polypeptide mitogens. 67
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy. 66
Insulin reduces HBsAg production by PLC/PRF/5 human hepatoma cell line. Brief report. 65
Induced underglycosylation of PLC/PRF/5 human hepatoma cells. Brief report. 63
Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors. 63
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice. 63
Heterogeneity of West Nile virus genotype 1a in Italy, 2011. 63
Effect of insulin on an insulin receptor of PLC/PRF/5 human hepatoma cell line. 62
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group 62
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 61
Human case of autochthonous West Nile virus lineage 2 infection in Italy, September 2011. 60
53. Togaviridae 59
Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment. 59
60. Hepeviridae 58
[Pulmonitis caused by Coxiella burneti and Chlamydia psittaci. 2 years of research in Marche] 58
Hepatitis e in Italy: 5 years of national epidemiological, virological and environmental surveillance, 2012 to 2016 58
Human papillomavirus infections: new perspectives for prevention and treatment. 57
Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 (HIV-1) infection 57
High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype. 57
Rapid spread of the novel respiratory syncytial virus A ON1 genotype, central Italy, 2011 to 2013. 57
Are three generations of quantitative molecular methods sufficient in medical virology? Brief review 57
Expression of high- and low-affinity epidermal growth factor receptors in human hepatoma cell lines 57
Sequence analysis of the hepatitis B virus pre-C region in hepatocellular carcinoma [HCC] and nontumoral liver tissues from HCC patients. 56
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 56
Clinical implications of HIV dynamics and drug resistance in macrophages. Review. 55
HIV avidity index performance using a modified fourth-generation immunoassay to detect recent HIV infections 55
ANCA-Associated Glomerulonephritis and Anti-Phospholipid Syndrome in a Patient with SARS-CoV-2 Infection: Just a Coincidence? 55
Growth-factor independence of a new differentiated hepatitis B virus DNA-negative human hepatoma cell line. 54
Italian Patent with european extension: New molecular vector for the geno-phenotypic characteristics of V3 sequences of the HIV gp120. 54
Molecular epidemiology and pathogenetic potential of underdiagnosed human papillomavirus types. 54
Totale 7.562
Categoria #
all - tutte 51.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.788


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020501 0 0 0 0 0 1 143 4 132 29 35 157
2020/20211.826 80 223 293 23 172 101 192 108 203 162 211 58
2021/20221.133 53 291 31 55 12 34 85 85 50 60 136 241
2022/20232.573 190 170 185 189 158 922 4 125 456 9 121 44
2023/20241.147 187 33 72 153 217 205 24 63 10 34 20 129
2024/2025647 261 180 104 10 62 30 0 0 0 0 0 0
Totale 9.246